Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders; Substance-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000318

R01-09803-1

NIDA-09803-1

Details and patient eligibility

About

The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.

Enrollment: 202 patients

Sex: All

Ages: 21 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

202 participants in 2 patient groups

1

Experimental group

Description:

Maintenance treatment with daily medication

Treatment:

Drug: Buprenorphine

2

Experimental group

Description:

Maintenance treatment with thrice-weekly medication

Treatment:

Drug: Buprenorphine